The studies demonstrated body composition improvements without effects on serum IGF-1 levels, carbohydrate metabolism, or insulin sensitivity
Explore the components individually: BPC-157 research peptide and TB-500 research peptide
Brenda and our expert team do not believe in one-size-fits-all solutions
Some preclinical studies show that BPC-157 can reduce inflammation and protect tissues in animal models, and those effects involve modulation of inflammatory responses and signaling pathways that overlap with immune activity
Health Canada has not approved BPC-157 for any indication, and the August 2025 Canada Peptide advisory listed BPC-157 among seized unauthorized injectable peptide drugs
Powell, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Biofilms, a section of the journal Frontiers in Cellular and Infection Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
